Moderna is leveraging its mRNA platform to expand beyond COVID-19 vaccines into RSV and oncology therapeutics. Vertex Pharmaceuticals maintains market dominance in cystic fibrosis while successfully ...
Vertex faced downward price pressure from biotech sector weakness and technical selling.Core fundamentals remain supported by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results